ASC deficient mice and mice treated with MCC950, a novel NLRP3 inflammasome inhibitor, are protected from salt-induced renal inflammation, fibrosis and hypertension (Krishnan et al., 2016; Krishnan et al., 2019). This evidence concerns the gene NLRP3 and hypertensive disorder.